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Background
Treatment of localized tumor by chemotherapy is mostly
used as an adjuvant to surgery to protect against or delay
the progression of disseminated metastatic diseases or for
treatment when other local therapies, such as surgery are
not feasible. Local drug delivery offers high potential as a
therapeutic choice against premature oncological stages or
with isolated cancers since it is more effective in reducing
cancer recurrences and avoiding the undesirable side
effects of drug spreading along the body [1]. Several appli-
cations of the bacterial cellulose in the biomedical field
were proposed, like wound healing membranes based on
the similarities to the human skin, artificial blood vessels,
and as replacement of cornea, valve prosthesis, urethra,
cartilage, etc. Also, the use of cellulose membranes has
been postulated for drug delivery of hormones and
proteins and it was recently fully reviewed [2,3].
Doxorubicin hydrochloride (dox) is commonly used in the
treatment of many solid tumors, such as breast, lung,
stomach or ovarian cancer and sarcoma [4]. In the present
work, we develop a bacterial cellulose membrane for
encapsulation of Doxorubicin and containing l-Carr and
CaCO3 as a potential implant device for local treatment of
solid tumors. The in vitro Dox release kinetics from the
matrices was studied at different pH values and also in
different matrices.
Methods
The system of bacterial cellulose containing hybrid micro-
particles (HMPs) was carried out by colloidal crystalliza-
tion in the presence of CaCl2, glycine (Gly), Na2CO3 and
l-carrageenan (Carr) [5]. To evaluate the potential for
incorporation of chemotherapy, the hybrid system was
immersed in a doxorubicin solution (Dox). The in vitro
kinetics was carried out in PBS buffer.
Results end conclusions
The developed systems have the advantages of being
synthesized on bacterialcellulose, a biomaterial broadly
used in many biomedicalengineering applications, where
cellulose is used as a physical support and a biological
scaffold for tissue formation. Addition of Carr to the
matrix raises the Dox loading only to 16.6%. However, the
presence of CaCO3 raises up to 83.3% and 87.3% the Dox
loaded into BC and BC-Carr, respectively. The presence of
HMPs attached to MC allowed the increase of the Dox
loading and made strict control of the drug release
produced by local changes of pH made by tumoral cells.
The Dox administration can be modulated by the amount
of Dox required in the treatment and also by the amount
of CaCO3 and their crystallization conditions.
The system has the simplicity of Dox encapsulation in
the HMPs by a technical procedure that allows to establish
the amount of Dox/matrix required for specific treatment.
The high loading capability of the Dox-CaCO3-Carr-BC
matrix is advantageous since it is reducing the drug waste.
Finally, the biodegradable matrix could be used for the
treatment of oncological pathologies, particularly for
breast cancer by local delivery of doxorubicin and defining
the amount of drug to be released.
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